Affimed (NASDAQ: AFMD) reported Q3 EPS of (EUR0.94), EUR0.09 worse than the analyst estimate of (EUR0.85). Revenue for the quarter came in at EUR150 thousand versus the consensus estimate of EUR1.42 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.